Solid Biosciences Inc.

8-K Shareholder vote results Jun 10, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Director or officer change Apr 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Regulation FD disclosure; Other events Mar 12, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Other events Mar 6, 2026 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 8-K Other events May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Entered a material agreement; Other events Feb 18, 2025 8-K Other events Feb 18, 2025 8-K Results of operations (earnings release); Other events Feb 18, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change; Shareholder vote results Jun 11, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure; Other events Jan 8, 2024 8-K Regulation FD disclosure; Other events Nov 15, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Director or officer change; Shareholder vote results Jun 9, 2023 8-K Director or officer change May 22, 2023 10-Q Quarter ended 2023-03-31 May 11, 2023 10-K Fiscal year ended 2022-12-31 Mar 23, 2023 8-K Regulation FD disclosure Mar 20, 2023 8-K Regulation FD disclosure Mar 13, 2023 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events Jan 9, 2023 8-K Entered a material agreement; Completed an acquisition or disposition; Exit or disposal costs; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Dec 5, 2022 8-K Director or officer change; Shareholder vote results; Other events Dec 1, 2022 10-Q Quarter ended 2022-09-30 Nov 10, 2022 8-K Modified rights of security holders; Amended charter or bylaws Oct 27, 2022 8-K Regulation FD disclosure Sep 30, 2022 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Sep 30, 2022 8-K Results of operations (earnings release) Aug 11, 2022 10-Q Quarter ended 2022-06-30 Aug 11, 2022